🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

9,250 results for “IO” Clear

  1. fecal microbiota transplantation

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Ulcerative Colitis

    approved small molecule active

    1 trial

  2. first-line scheme+compound kushen injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Advanced Colorectal Carcinoma

    approved small molecule active

    1 trial

  3. fluocinolone acetonide 190 micrograms

    ANI PHARMACEUTICALS INC

    Non-infectious Uveitis Affecting the Posterior Segment of the Eye

    approved small molecule active

    1 trial

  4. fluticasone/salmeterol, tiotropium

    Hospital Authority, Hong Kong

    COPD

    approved small molecule active

    1 trial

  5. gastric scintigraphy

    Hospital Authority, Hong Kong

    Functional Dyspepsia

    approved other terminated

    1 trial

  6. glatiramer acetate injection with oral cetirizine hydrochloride

    Teva Pharma GmbH

    Multiple Sclerosis

    approved small molecule completed

    1 trial

  7. hepatitis B vaccine made by Recombinant DNA Techniques in Saccharomyces Cerevisiae

    BRIGHT MINDS BIOSCIENCES INC.

    Hepatitis B Vaccines

    approved mab completed

    1 trial

  8. hyaluronidase (human recombinant)/rehydration fluid

    HALOZYME THERAPEUTICS, INC.

    Dehydration

    approved small molecule completed

    1 trial

  9. hydroxyethl starch

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cesarean Section

    approved small molecule completed

    1 trial

  10. hylenex-facilitated subcutaneous Lactated Ringer's infusion

    HALOZYME THERAPEUTICS, INC.

    Dehydration

    approved small molecule completed

    1 trial

  11. inhaled treprostinil

    United Therapeutics Europe Ltd

    Pulmonary Arterial Hypertension

    approved small molecule terminated

    3 trials

  12. insulin lispro injection, exenatide injection

    The First People's Hospital of Lianyungang

    Diabetes Mellitus, Type 2

    approved small molecule completed

    1 trial

  13. intravenous tranexamic acid (TXA) infusion

    The First People's Hospital of Lianyungang

    Spontaneous Intracranial Hemorrhage

    approved small molecule active

    1 trial

  14. iodixanol

    The First People's Hospital of Lianyungang

    Kidney Failure, Chronic

    approved small molecule active

    1 trial

  15. lactulose (Kristalose®)

    CUMBERLAND PHARMACEUTICALS INC

    Constipation

    approved small molecule completed

    1 trial

  16. laronidase

    BioMarin Pharmaceutical Australia Pty Ltd

    Mucopolysaccharidosis I

    approved small molecule completed

    3 trials

  17. low-dose rivaroxaban

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Atrial Fibrillation

    approved small molecule active

    1 trial

  18. lubiprostone

    Takeda

    Chronic Idiopathic Constipation

    approved small molecule completed

    3 trials

  19. medication for opioid use disorder

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    approved small molecule completed

    1 trial

  20. melphalan hydrochloride for injection

    CASI Pharmaceuticals

    Multiple Myeloma

    approved small molecule active

    2 trials

  21. methadone

    BRIGHT MINDS BIOSCIENCES INC.

    Heroin Dependence

    approved small molecule completed

    1 trial

  22. midazolam

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Mechanical Ventilation

    approved small molecule active

    1 trial

  23. midodrine hydrochloride (ProAmatine®)

    Takeda

    Hypotension, Orthostatic

    approved small molecule terminated

    1 trial

  24. miglustat

    Ultragenyx UK Limited

    GM1 Gangliosidoses

    approved small molecule terminated

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources